Sero-prevalence of rubella among pregnant women in India, 2017

Vaccine. 2018 Dec 18;36(52):7909-7912. doi: 10.1016/j.vaccine.2018.11.013. Epub 2018 Nov 15.

Abstract

Background: We conducted a sero-survey among pregnant women attending antenatal clinics of six hospitals which also function as sentinel sites for CRS surveillance, to estimate the prevalence of IgG antibodies against rubella.

Methods: We systematically sampled 1800 pregnant women attending antenatal clinics and tested their sera for IgG antibodies against rubella. We classified sera as seropositive (titre ≥10 IU/ml), sero-negative (titre <8 IU/ml) or indeterminate (titre 8-9.9 IU/ml) per manufacturer's instructions. In a sub-sample, we estimated the titers of IgG antibodies against rubella. IgG titer of ≥10 IU/mL was considered protective.

Results: Of 1800 sera tested, 1502 (83.4%) were seropositive and 24 (1.3%) were indeterminate and 274 (15.2%) were sero-negative. Rubella sero-positivity did not differ by age group, educational status or place of residence. Three hundred and eighty three (87.8%) of the 436 sera had IgG concentrations ≥10 IU/mL.

Conclusion: The results of the serosurvey indicate high levels of rubella sero-positivity in pregnant women. High sero-prevalence in the absence of routine childhood immunization indicates continued transmission of rubella virus in cities where sentinel sites are located.

Keywords: India; Rubella virus; Sero-prevalence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Viral / blood*
  • Cross-Sectional Studies
  • Female
  • Humans
  • Immunoglobulin G / blood
  • India / epidemiology
  • Pregnancy
  • Pregnancy Complications, Infectious / epidemiology*
  • Pregnant Women
  • Prevalence
  • Rubella / epidemiology*
  • Rubella virus
  • Sentinel Surveillance
  • Seroepidemiologic Studies
  • Tertiary Care Centers
  • Vaccination / statistics & numerical data
  • Young Adult

Substances

  • Antibodies, Viral
  • Immunoglobulin G